Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.

CONCLUSION: Our results suggest that cyclin CDK1, CCNB1, and CCNA2 are overexpressed in TNBC and they could act as novel biomarkers for the diagnosis and treatment of TNBC.
PMID: 32338339 [PubMed - as supplied by publisher]

Source: Breast Cancer - April 26, 2020 Category: Cancer & Oncology Authors: Lu Y, Yang G, Xiao Y, Zhang T, Su F, Chang R, Ling X, Bai Y Tags: Breast Cancer Source Type: research